-
Societal and Economic Impact of Immunotherapy for NSCLC Treatment in Bulgaria
Sep 9, 2025, 16:22 PM -
Estimation of HER2-Negative Metastatic Breast Cancer Population Eligible for Innovative Treatments in France
Sep 9, 2025, 16:22 PM -
Design Operating Characteristics in a Noninterventional Study Framework
Sep 9, 2025, 16:22 PM -
Characterizing the UK Population Living With Von Willebrand Disease: Foundational Data for Health Economics and Outcomes Research
Sep 9, 2025, 16:22 PM -
Costing Analysis for the Management of Localized Renal Cell Carcinoma From the UK NHS Perspective
Sep 9, 2025, 16:22 PM -
Cost-Savings Analysis of Fitusiran Prophylaxis: Reducing Breakthrough Bleeding Treatment Expenditure in the Kingdom of Saudi Arabia
Sep 9, 2025, 16:22 PM -
A Review of Information Uncertainty in Oncology Treatment Preferences
Sep 9, 2025, 16:22 PM -
Gender Differences in the Economic Burden of Alcohol Use in Belgium
Sep 9, 2025, 16:22 PM -
Comorbidities and Comedication Among Individuals in Treatment for ADHD: A Danish Nationwide Study
Sep 9, 2025, 16:22 PM -
Disability Resource Utilization and Caregiver Support Among a Real-World Sample of Patients With Transthyretin Amyloidosis With Polyneuropathy
Sep 9, 2025, 16:22 PM -
Thecosystem: A Systemwide Health and Social Care Decision Analytical Model to Assess Population-Based Interventions for Older People’s Care in the UK
Sep 9, 2025, 16:22 PM -
Projected Rapid-Growing Economic Burden of Chronic Respiratory Multimorbidity in Singapore: Unveiling Diagnostic Gaps and Asian Phenotypes Through Health Administrative Data
Sep 9, 2025, 16:22 PM -
Healthcare Expenditure for Treatment of Cardiovascular Disease Among Hypercholesterolemia Patients in Japan: A Claims Data Analysis
Sep 9, 2025, 16:22 PM -
Impact of Anosmia Severity on Health Utility Values in Chronic Rhinosinusitis With Nasal Polyps: An Exploratory Analysis From the WAYPOINT Trial
Sep 9, 2025, 16:22 PM -
Global Access to Innovative Medicines in 2025: Europe’s Gaps and the UK’s Continued Decline
Sep 9, 2025, 16:22 PM -
Budget Impact of a Minimally Invasive Surgical Treatment for Benign Prostatic Obstruction in Italian Healthcare Service
Sep 9, 2025, 16:22 PM -
Real-World Burden of Illness in Patients With ER+/HER2- ABC Receiving Second-Line Treatment: Interim Results of Longitudinal Health Utility Data
Sep 9, 2025, 16:22 PM -
Quantifying the Fiscal Value of Prevention Programs for Depression
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Pembrolizumab in Combination With Enfortumab Vendotin for First-Line Treatment of Previously Untreated Locally Advanced or Metastatic Urothelial Carcinoma
Sep 9, 2025, 16:22 PM -
Comparative Analysis of Reimbursement Decisions for Advanced Oncology Combination Therapies in England and Japan
Sep 9, 2025, 16:22 PM
